Psychiatric comorbidity is associated with drug use and HIV risk in syringe exchange participants

Elizabeth Disney, Michael Kidorf, Ken Kolodner, Van King, Jessica M Peirce, Peter Beilenson, Robert Brooner

Research output: Contribution to journalArticle

Abstract

The present study evaluated the effects of psychiatric comorbidity on substance use disorder prevalence, HIV risk behavior, and other problem severity in male and female out-of-treatment injection drug users newly registered at a syringe exchange program. Participants (N = 338) were administered the Structured Clinical Interview for the DSM-IV, the Addiction Severity Index, and the Risk Assessment Battery, and classified into one of four diagnostic groups: (1) no antisocial personality disorder (APD) or Axis I psychiatric disorder (N = 162), (2) APD only (N = 74), (3) Axis I psychiatric disorder only (N = 55), or (4) APD plus Axis I psychiatric disorder (N = 47). Psychiatric comorbidity was associated with higher rates of substance use disorder and more HIV risk and other problem severity. In general, participants with both APD and an Axis I disorder exhibited the most problem severity. APD was uniquely associated with higher prevalence for each substance use disorder assessed in this study and with elevated HIV risk. These results support and extend studies conducted with opioid-dependent individuals recruited from treatment and community settings, and reinforce the need to develop interventions to encourage syringe exchange program participants to enroll in treatment.

Original languageEnglish (US)
Pages (from-to)577-583
Number of pages7
JournalJournal of Nervous and Mental Disease
Volume194
Issue number8
DOIs
StatePublished - Aug 2006

Fingerprint

Antisocial Personality Disorder
Syringes
Psychiatry
Comorbidity
HIV
Needle-Exchange Programs
Substance-Related Disorders
Pharmaceutical Preparations
Risk-Taking
Drug Users
Diagnostic and Statistical Manual of Mental Disorders
Opioid Analgesics
Therapeutics
Interviews
Injections

Keywords

  • HIV risk behavior
  • Opioid users
  • Psychiatric comorbidity
  • Syringe exchange

ASJC Scopus subject areas

  • Psychiatry and Mental health

Cite this

Psychiatric comorbidity is associated with drug use and HIV risk in syringe exchange participants. / Disney, Elizabeth; Kidorf, Michael; Kolodner, Ken; King, Van; Peirce, Jessica M; Beilenson, Peter; Brooner, Robert.

In: Journal of Nervous and Mental Disease, Vol. 194, No. 8, 08.2006, p. 577-583.

Research output: Contribution to journalArticle

@article{364ffd37821b499cba03afcd42fc5ac1,
title = "Psychiatric comorbidity is associated with drug use and HIV risk in syringe exchange participants",
abstract = "The present study evaluated the effects of psychiatric comorbidity on substance use disorder prevalence, HIV risk behavior, and other problem severity in male and female out-of-treatment injection drug users newly registered at a syringe exchange program. Participants (N = 338) were administered the Structured Clinical Interview for the DSM-IV, the Addiction Severity Index, and the Risk Assessment Battery, and classified into one of four diagnostic groups: (1) no antisocial personality disorder (APD) or Axis I psychiatric disorder (N = 162), (2) APD only (N = 74), (3) Axis I psychiatric disorder only (N = 55), or (4) APD plus Axis I psychiatric disorder (N = 47). Psychiatric comorbidity was associated with higher rates of substance use disorder and more HIV risk and other problem severity. In general, participants with both APD and an Axis I disorder exhibited the most problem severity. APD was uniquely associated with higher prevalence for each substance use disorder assessed in this study and with elevated HIV risk. These results support and extend studies conducted with opioid-dependent individuals recruited from treatment and community settings, and reinforce the need to develop interventions to encourage syringe exchange program participants to enroll in treatment.",
keywords = "HIV risk behavior, Opioid users, Psychiatric comorbidity, Syringe exchange",
author = "Elizabeth Disney and Michael Kidorf and Ken Kolodner and Van King and Peirce, {Jessica M} and Peter Beilenson and Robert Brooner",
year = "2006",
month = "8",
doi = "10.1097/01.nmd.0000230396.17230.28",
language = "English (US)",
volume = "194",
pages = "577--583",
journal = "Journal of Nervous and Mental Disease",
issn = "0022-3018",
publisher = "Lippincott Williams and Wilkins",
number = "8",

}

TY - JOUR

T1 - Psychiatric comorbidity is associated with drug use and HIV risk in syringe exchange participants

AU - Disney, Elizabeth

AU - Kidorf, Michael

AU - Kolodner, Ken

AU - King, Van

AU - Peirce, Jessica M

AU - Beilenson, Peter

AU - Brooner, Robert

PY - 2006/8

Y1 - 2006/8

N2 - The present study evaluated the effects of psychiatric comorbidity on substance use disorder prevalence, HIV risk behavior, and other problem severity in male and female out-of-treatment injection drug users newly registered at a syringe exchange program. Participants (N = 338) were administered the Structured Clinical Interview for the DSM-IV, the Addiction Severity Index, and the Risk Assessment Battery, and classified into one of four diagnostic groups: (1) no antisocial personality disorder (APD) or Axis I psychiatric disorder (N = 162), (2) APD only (N = 74), (3) Axis I psychiatric disorder only (N = 55), or (4) APD plus Axis I psychiatric disorder (N = 47). Psychiatric comorbidity was associated with higher rates of substance use disorder and more HIV risk and other problem severity. In general, participants with both APD and an Axis I disorder exhibited the most problem severity. APD was uniquely associated with higher prevalence for each substance use disorder assessed in this study and with elevated HIV risk. These results support and extend studies conducted with opioid-dependent individuals recruited from treatment and community settings, and reinforce the need to develop interventions to encourage syringe exchange program participants to enroll in treatment.

AB - The present study evaluated the effects of psychiatric comorbidity on substance use disorder prevalence, HIV risk behavior, and other problem severity in male and female out-of-treatment injection drug users newly registered at a syringe exchange program. Participants (N = 338) were administered the Structured Clinical Interview for the DSM-IV, the Addiction Severity Index, and the Risk Assessment Battery, and classified into one of four diagnostic groups: (1) no antisocial personality disorder (APD) or Axis I psychiatric disorder (N = 162), (2) APD only (N = 74), (3) Axis I psychiatric disorder only (N = 55), or (4) APD plus Axis I psychiatric disorder (N = 47). Psychiatric comorbidity was associated with higher rates of substance use disorder and more HIV risk and other problem severity. In general, participants with both APD and an Axis I disorder exhibited the most problem severity. APD was uniquely associated with higher prevalence for each substance use disorder assessed in this study and with elevated HIV risk. These results support and extend studies conducted with opioid-dependent individuals recruited from treatment and community settings, and reinforce the need to develop interventions to encourage syringe exchange program participants to enroll in treatment.

KW - HIV risk behavior

KW - Opioid users

KW - Psychiatric comorbidity

KW - Syringe exchange

UR - http://www.scopus.com/inward/record.url?scp=33747333920&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33747333920&partnerID=8YFLogxK

U2 - 10.1097/01.nmd.0000230396.17230.28

DO - 10.1097/01.nmd.0000230396.17230.28

M3 - Article

C2 - 16909065

AN - SCOPUS:33747333920

VL - 194

SP - 577

EP - 583

JO - Journal of Nervous and Mental Disease

JF - Journal of Nervous and Mental Disease

SN - 0022-3018

IS - 8

ER -